Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3Recruiting 2Active not recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 341Ovarian Neoplasms 177Lung Neoplasms 171Breast Neoplasms 118Fallopian Tube Neoplasms 87Neoplasms 79Carcinoma, Ovarian Epithelial 69Squamous Cell Carcinoma of Head and Neck 51Small Cell Lung Carcinoma 49Triple Negative Breast Neoplasms 41Adenocarcinoma of Lung 41Head and Neck Neoplasms 40Neoplasm Metastasis 37Neuroblastoma 34Central Nervous System Neoplasms 33Endometrial Neoplasms 28Esophageal Neoplasms 27Carcinoma 27Brain Neoplasms 27Lymphoma 26Recurrence 25Lymphoma, Large B-Cell, Diffuse 25Urinary Bladder Neoplasms 24Parkinson Disease 4, Autosomal Dominant Lewy Body 24Adenocarcinoma, Bronchiolo-Alveolar 23Testicular Neoplasms 22Astrocytoma 22Melanoma 19Uterine Cervical Neoplasms 18Prostatic Neoplasms 18

Interventions

Cisplatin 22Radiotherapy, Intensity-Modulated 12Fluorouracil 9Gemcitabine 7Docetaxel 7Cetuximab 5Capecitabine 5pembrolizumab 4nimotuzumab 3nedaplatin 3Radiotherapy 3Radiation 3Carboplatin 3toripalimab 2spartalizumab 2camrelizumab 2anlotinib 2Quality of Life 2Protons 2Paclitaxel 2Nivolumab 2Dexamethasone 2Chemoradiotherapy 2tislelizumab 1raltitrexed 1penpulimab 1icotinib 1fosaprepitant 1famitinib 1endostar protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Nasopharyngeal Carcinoma × Carboplatin × Clear all
NCT02578641 2023-06-28

VANCE

Tessa Therapeutics

Phase 3 Completed
330 enrolled 18 charts
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Nose Neoplasms, Epstein-Barr Virus Infections

NCT00953420 2017-08-18

CADEN

Baylor College of Medicine

Phase 2 Completed
20 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Ministry of Health, Malaysia

Phase 2 Completed
18 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡